Acorda Therapeutics, Inc. (Nasdaq:ACOR) will host a Research and Development (R&D) Day for the investment community on Tuesday, November 5, 2013 from 9:00 a.m. to 12:00 p.m. at Alexandria Center for Life Sciences in New York City (450 East 29th Street at First Avenue).
Members of Acorda’s management team, including President and CEO Ron Cohen, M.D., Chief Scientific Officer Andrew Blight, Ph.D., Chief Medical Officer Enrique Carrazana., M.D., and VP, Research and Development Anthony Caggiano, M.D., Ph.D., will review Acorda’s six clinical-stage programs. Presentations will include development programs in post-stroke deficits, cluster seizures, heart failure, neuropathic pain, multiple sclerosis and spinal cord injury.
Help employers find you! Check out all the jobs and post your resume.
